» Articles » PMID: 35002323

Partial Breast Reconstruction with Lateral Chest Wall Perforator Flap to Facilitate Breast Conservation in Breast Cancer: First 100 Cases with Cancer Outcomes at 8 Years Follow-Up and the Lessons Learned

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2022 Jan 10
PMID 35002323
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This is a prospective cohort study of partial breast reconstruction (PBR) with a lateral chest wall perforator flap (LCWPF) to facilitate breast conservation surgery (BCS) for women undergoing surgery for breast cancer. The study was undertaken to study the clinical and cancer outcomes.

Methods: Patients diagnosed with ductal carcinoma in situ (DCIS) or breast cancer who consented to undergo BCS with PBR with LCWPF were included in the study. A prospective database has been maintained to collect information on clinico-pathological features, complications, and follow-up. Patients were asked to complete an anonymised PROM questionnaire over the years. The hospital electronic records were interrogated for women who have completed 5 years follow-up to assess for development of recurrence/events.

Results: A total of 105 patients underwent PBR with LCWPFs between 2011 and 2018. Of these, 74% underwent cancer resection and PBR as one operation whilst 26% underwent PBR as a two-stage approach. The median tumor size on pre-op imaging was 30 mm for the one-stage approach and 39.5 mm for the two-stage approach (-value=0.003). The complication rates were low and the re-operation rate for close margins was 10%, with 4% eventually requiring mastectomy. Good-to-excellent esthetic outcomes were reported in more than 80% of cases by patients and clinicians. The local recurrence rate (LR) was 2%, distant recurrence rate 10.5%, disease free survival (DFS) 86%, distant disease-free survival (DDFS) 89% and overall survival (OS) 94.8% at 4.5 years median follow-up. This procedure provides an effective oncological approach, avoiding mastectomy with a good-to-excellent cosmetic outcome. The follow-up data establishes the safety of this approach.

Discussion: This is the first published series of recurrence and survival data in patients undergoing PBR. We intend to continue with data collection to assess long-term outcomes beyond 10 years. The authors would recommend consideration of this technique to facilitate BCS and avoid mastectomy.

Registration: Not applicable.

Citing Articles

Application of chest wall perforator flaps in oncoplastic breast-conserving surgery.

Xie L, Kong X, Lin D, Song J, Chen X, Huang P BMC Cancer. 2025; 25(1):328.

PMID: 39984927 PMC: 11846177. DOI: 10.1186/s12885-025-13488-3.


Chest wall perforator flap reconstruction in breast conserving surgery: quality of life and limited complications in outpatient treatment.

van Zeelst L, Straten R, van Eekeren R, van Uden D, de Wilt J, Strobbe L World J Surg Oncol. 2025; 23(1):17.

PMID: 39849532 PMC: 11755791. DOI: 10.1186/s12957-024-03638-5.


Molecular heterogeneity and MYC dysregulation in triple-negative breast cancer: genomic advances and therapeutic implications.

Priya , Kumar A, Kumar D 3 Biotech. 2025; 15(1):33.

PMID: 39777154 PMC: 11700964. DOI: 10.1007/s13205-024-04195-0.


Chest wall perforator flap partial breast reconstruction: a retrospective analysis of surgical, cosmetic and survival outcome.

Agrawal S, Mahajan S, Ahmed R, Shruti N, Sharma A Ecancermedicalscience. 2024; 18:1681.

PMID: 38566767 PMC: 10984835. DOI: 10.3332/ecancer.2024.1681.


[Update and Trends in Breast Reconstruction After Mastectomy].

Supper P, Semmler L, Placheta-Gyori E, Teufelsbauer M, Harik-Chraim E, Radtke C Handchir Mikrochir Plast Chir. 2023; 55(4):253-261.

PMID: 37487507 PMC: 10415025. DOI: 10.1055/a-2082-1542.


References
1.
Goyal A, Dodwell D . POSNOC: A Randomised Trial Looking at Axillary Treatment in Women with One or Two Sentinel Nodes with Macrometastases. Clin Oncol (R Coll Radiol). 2015; 27(12):692-5. DOI: 10.1016/j.clon.2015.07.005. View

2.
Bertozzi N, Pesce M, Santi P, Raposio E . Oncoplastic breast surgery: comprehensive review. Eur Rev Med Pharmacol Sci. 2017; 21(11):2572-2585. View

3.
Litiere S, Werutsky G, Fentiman I, Rutgers E, Christiaens M, Van Limbergen E . Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012; 13(4):412-9. DOI: 10.1016/S1470-2045(12)70042-6. View

4.
Youssif S, Hassan Y, Tohamy A, Eid S, Ashour T, Malahias M . Pedicled local flaps: a reliable reconstructive tool for partial breast defects. Gland Surg. 2019; 8(5):527-536. PMC: 6842754. DOI: 10.21037/gs.2019.09.06. View

5.
Waljee J, Hu E, Ubel P, Smith D, Newman L, Alderman A . Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol. 2008; 26(20):3331-7. DOI: 10.1200/JCO.2007.13.1375. View